Prevalence of Crohn’s disease has increased in developing countries owing to industrialization, environmental factors such as differences in exposure to sunlight, changes in diet, smoking, and genetic characteristics. According to the Centers for Disease Control and Prevention (CDC), over 1 million Americans suffer from inflammatory bowel disease every year.
Growing prevalence of the disease, along with increase in number of pipeline drugs, is expected to be a key factor driving the market.
Market Analysis and Insights: Global Crohn’s Disease Therapeutics Market
The global Crohn’s Disease Therapeutics market size is projected to reach US$ 3712.2 million by 2026, from US$ 3423 million in 2020, at a CAGR of 1.4% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Crohn’s Disease Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Crohn’s Disease Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Crohn’s Disease Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Crohn’s Disease Therapeutics market.
Crohn’s Disease Therapeutics Breakdown Data by Type
Non-Surgical
Surgical
Crohn’s Disease Therapeutics Breakdown Data by Application
Hospitals
Ambulatory Surgical Centers
Based on regional and country-level analysis, the Crohn’s Disease Therapeutics market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Crohn’s Disease Therapeutics market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The following players are covered in this report:
Johnson and Johnson Services Inc.
Pfizer Inc.
Allergan
AbbVie Inc.
Takeda Pharmaceutical Company Limited
Celgene Corporation
Perrigo Company PLC
Ferring B.V.
Salix Pharmaceuticals
Gilead Sciences Inc.
Genentech Inc.
UCB India Private Limited.
Growing prevalence of the disease, along with increase in number of pipeline drugs, is expected to be a key factor driving the market.
Market Analysis and Insights: Global Crohn’s Disease Therapeutics Market
The global Crohn’s Disease Therapeutics market size is projected to reach US$ 3712.2 million by 2026, from US$ 3423 million in 2020, at a CAGR of 1.4% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Crohn’s Disease Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Crohn’s Disease Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Crohn’s Disease Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Crohn’s Disease Therapeutics market.
Crohn’s Disease Therapeutics Breakdown Data by Type
Non-Surgical
Surgical
Crohn’s Disease Therapeutics Breakdown Data by Application
Hospitals
Ambulatory Surgical Centers
Based on regional and country-level analysis, the Crohn’s Disease Therapeutics market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Crohn’s Disease Therapeutics market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The following players are covered in this report:
Johnson and Johnson Services Inc.
Pfizer Inc.
Allergan
AbbVie Inc.
Takeda Pharmaceutical Company Limited
Celgene Corporation
Perrigo Company PLC
Ferring B.V.
Salix Pharmaceuticals
Gilead Sciences Inc.
Genentech Inc.
UCB India Private Limited.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Crohn’s Disease Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Non-Surgical
1.2.3 Surgical
1.3 Market by Application
1.3.1 Global Crohn’s Disease Therapeutics Market Share by Application: 2020 VS 2026
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Crohn’s Disease Therapeutics Market Perspective (2015-2026)
2.2 Global Crohn’s Disease Therapeutics Growth Trends by Regions
2.2.1 Crohn’s Disease Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Crohn’s Disease Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Crohn’s Disease Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Crohn’s Disease Therapeutics Players by Market Size
3.1.1 Global Top Crohn’s Disease Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Crohn’s Disease Therapeutics Revenue Market Share by Players (2015-2020)
3.2 Global Crohn’s Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Crohn’s Disease Therapeutics Revenue
3.4 Global Crohn’s Disease Therapeutics Market Concentration Ratio
3.4.1 Global Crohn’s Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Crohn’s Disease Therapeutics Revenue in 2019
3.5 Key Players Crohn’s Disease Therapeutics Area Served
3.6 Key Players Crohn’s Disease Therapeutics Product Solution and Service
3.7 Date of Enter into Crohn’s Disease Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Crohn’s Disease Therapeutics Breakdown Data by Type (2015-2026)
4.1 Global Crohn’s Disease Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Crohn’s Disease Therapeutics Forecasted Market Size by Type (2021-2026)
5 Crohn’s Disease Therapeutics Breakdown Data by Application (2015-2026)
5.1 Global Crohn’s Disease Therapeutics Historic Market Size by Application (2015-2020)
5.2 Global Crohn’s Disease Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Crohn’s Disease Therapeutics Market Size (2015-2026)
6.2 North America Crohn’s Disease Therapeutics Market Size by Type (2015-2020)
6.3 North America Crohn’s Disease Therapeutics Market Size by Application (2015-2020)
6.4 North America Crohn’s Disease Therapeutics Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Crohn’s Disease Therapeutics Market Size (2015-2026)
7.2 Europe Crohn’s Disease Therapeutics Market Size by Type (2015-2020)
7.3 Europe Crohn’s Disease Therapeutics Market Size by Application (2015-2020)
7.4 Europe Crohn’s Disease Therapeutics Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Crohn’s Disease Therapeutics Market Size (2015-2026)
8.2 China Crohn’s Disease Therapeutics Market Size by Type (2015-2020)
8.3 China Crohn’s Disease Therapeutics Market Size by Application (2015-2020)
8.4 China Crohn’s Disease Therapeutics Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Crohn’s Disease Therapeutics Market Size (2015-2026)
9.2 Japan Crohn’s Disease Therapeutics Market Size by Type (2015-2020)
9.3 Japan Crohn’s Disease Therapeutics Market Size by Application (2015-2020)
9.4 Japan Crohn’s Disease Therapeutics Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Crohn’s Disease Therapeutics Market Size (2015-2026)
10.2 Southeast Asia Crohn’s Disease Therapeutics Market Size by Type (2015-2020)
10.3 Southeast Asia Crohn’s Disease Therapeutics Market Size by Application (2015-2020)
10.4 Southeast Asia Crohn’s Disease Therapeutics Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Johnson and Johnson Services Inc.
11.1.1 Johnson and Johnson Services Inc. Company Details
11.1.2 Johnson and Johnson Services Inc. Business Overview
11.1.3 Johnson and Johnson Services Inc. Crohn’s Disease Therapeutics Introduction
11.1.4 Johnson and Johnson Services Inc. Revenue in Crohn’s Disease Therapeutics Business (2015-2020))
11.1.5 Johnson and Johnson Services Inc. Recent Development
11.2 Pfizer Inc.
11.2.1 Pfizer Inc. Company Details
11.2.2 Pfizer Inc. Business Overview
11.2.3 Pfizer Inc. Crohn’s Disease Therapeutics Introduction
11.2.4 Pfizer Inc. Revenue in Crohn’s Disease Therapeutics Business (2015-2020)
11.2.5 Pfizer Inc. Recent Development
11.3 Allergan
11.3.1 Allergan Company Details
11.3.2 Allergan Business Overview
11.3.3 Allergan Crohn’s Disease Therapeutics Introduction
11.3.4 Allergan Revenue in Crohn’s Disease Therapeutics Business (2015-2020)
11.3.5 Allergan Recent Development
11.4 AbbVie Inc.
11.4.1 AbbVie Inc. Company Details
11.4.2 AbbVie Inc. Business Overview
11.4.3 AbbVie Inc. Crohn’s Disease Therapeutics Introduction
11.4.4 AbbVie Inc. Revenue in Crohn’s Disease Therapeutics Business (2015-2020)
11.4.5 AbbVie Inc. Recent Development
11.5 Takeda Pharmaceutical Company Limited
11.5.1 Takeda Pharmaceutical Company Limited Company Details
11.5.2 Takeda Pharmaceutical Company Limited Business Overview
11.5.3 Takeda Pharmaceutical Company Limited Crohn’s Disease Therapeutics Introduction
11.5.4 Takeda Pharmaceutical Company Limited Revenue in Crohn’s Disease Therapeutics Business (2015-2020)
11.5.5 Takeda Pharmaceutical Company Limited Recent Development
11.6 Celgene Corporation
11.6.1 Celgene Corporation Company Details
11.6.2 Celgene Corporation Business Overview
11.6.3 Celgene Corporation Crohn’s Disease Therapeutics Introduction
11.6.4 Celgene Corporation Revenue in Crohn’s Disease Therapeutics Business (2015-2020)
11.6.5 Celgene Corporation Recent Development
11.7 Perrigo Company PLC
11.7.1 Perrigo Company PLC Company Details
11.7.2 Perrigo Company PLC Business Overview
11.7.3 Perrigo Company PLC Crohn’s Disease Therapeutics Introduction
11.7.4 Perrigo Company PLC Revenue in Crohn’s Disease Therapeutics Business (2015-2020)
11.7.5 Perrigo Company PLC Recent Development
11.8 Ferring B.V.
11.8.1 Ferring B.V. Company Details
11.8.2 Ferring B.V. Business Overview
11.8.3 Ferring B.V. Crohn’s Disease Therapeutics Introduction
11.8.4 Ferring B.V. Revenue in Crohn’s Disease Therapeutics Business (2015-2020)
11.8.5 Ferring B.V. Recent Development
11.9 Salix Pharmaceuticals
11.9.1 Salix Pharmaceuticals Company Details
11.9.2 Salix Pharmaceuticals Business Overview
11.9.3 Salix Pharmaceuticals Crohn’s Disease Therapeutics Introduction
11.9.4 Salix Pharmaceuticals Revenue in Crohn’s Disease Therapeutics Business (2015-2020)
11.9.5 Salix Pharmaceuticals Recent Development
11.10 Gilead Sciences Inc.
11.10.1 Gilead Sciences Inc. Company Details
11.10.2 Gilead Sciences Inc. Business Overview
11.10.3 Gilead Sciences Inc. Crohn’s Disease Therapeutics Introduction
11.10.4 Gilead Sciences Inc. Revenue in Crohn’s Disease Therapeutics Business (2015-2020)
11.10.5 Gilead Sciences Inc. Recent Development
11.11 Genentech Inc.
10.11.1 Genentech Inc. Company Details
10.11.2 Genentech Inc. Business Overview
10.11.3 Genentech Inc. Crohn’s Disease Therapeutics Introduction
10.11.4 Genentech Inc. Revenue in Crohn’s Disease Therapeutics Business (2015-2020)
10.11.5 Genentech Inc. Recent Development
11.12 UCB India Private Limited.
10.12.1 UCB India Private Limited. Company Details
10.12.2 UCB India Private Limited. Business Overview
10.12.3 UCB India Private Limited. Crohn’s Disease Therapeutics Introduction
10.12.4 UCB India Private Limited. Revenue in Crohn’s Disease Therapeutics Business (2015-2020)
10.12.5 UCB India Private Limited. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Crohn’s Disease Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Non-Surgical
1.2.3 Surgical
1.3 Market by Application
1.3.1 Global Crohn’s Disease Therapeutics Market Share by Application: 2020 VS 2026
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Crohn’s Disease Therapeutics Market Perspective (2015-2026)
2.2 Global Crohn’s Disease Therapeutics Growth Trends by Regions
2.2.1 Crohn’s Disease Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Crohn’s Disease Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Crohn’s Disease Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Crohn’s Disease Therapeutics Players by Market Size
3.1.1 Global Top Crohn’s Disease Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Crohn’s Disease Therapeutics Revenue Market Share by Players (2015-2020)
3.2 Global Crohn’s Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Crohn’s Disease Therapeutics Revenue
3.4 Global Crohn’s Disease Therapeutics Market Concentration Ratio
3.4.1 Global Crohn’s Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Crohn’s Disease Therapeutics Revenue in 2019
3.5 Key Players Crohn’s Disease Therapeutics Area Served
3.6 Key Players Crohn’s Disease Therapeutics Product Solution and Service
3.7 Date of Enter into Crohn’s Disease Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Crohn’s Disease Therapeutics Breakdown Data by Type (2015-2026)
4.1 Global Crohn’s Disease Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Crohn’s Disease Therapeutics Forecasted Market Size by Type (2021-2026)
5 Crohn’s Disease Therapeutics Breakdown Data by Application (2015-2026)
5.1 Global Crohn’s Disease Therapeutics Historic Market Size by Application (2015-2020)
5.2 Global Crohn’s Disease Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Crohn’s Disease Therapeutics Market Size (2015-2026)
6.2 North America Crohn’s Disease Therapeutics Market Size by Type (2015-2020)
6.3 North America Crohn’s Disease Therapeutics Market Size by Application (2015-2020)
6.4 North America Crohn’s Disease Therapeutics Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Crohn’s Disease Therapeutics Market Size (2015-2026)
7.2 Europe Crohn’s Disease Therapeutics Market Size by Type (2015-2020)
7.3 Europe Crohn’s Disease Therapeutics Market Size by Application (2015-2020)
7.4 Europe Crohn’s Disease Therapeutics Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Crohn’s Disease Therapeutics Market Size (2015-2026)
8.2 China Crohn’s Disease Therapeutics Market Size by Type (2015-2020)
8.3 China Crohn’s Disease Therapeutics Market Size by Application (2015-2020)
8.4 China Crohn’s Disease Therapeutics Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Crohn’s Disease Therapeutics Market Size (2015-2026)
9.2 Japan Crohn’s Disease Therapeutics Market Size by Type (2015-2020)
9.3 Japan Crohn’s Disease Therapeutics Market Size by Application (2015-2020)
9.4 Japan Crohn’s Disease Therapeutics Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Crohn’s Disease Therapeutics Market Size (2015-2026)
10.2 Southeast Asia Crohn’s Disease Therapeutics Market Size by Type (2015-2020)
10.3 Southeast Asia Crohn’s Disease Therapeutics Market Size by Application (2015-2020)
10.4 Southeast Asia Crohn’s Disease Therapeutics Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Johnson and Johnson Services Inc.
11.1.1 Johnson and Johnson Services Inc. Company Details
11.1.2 Johnson and Johnson Services Inc. Business Overview
11.1.3 Johnson and Johnson Services Inc. Crohn’s Disease Therapeutics Introduction
11.1.4 Johnson and Johnson Services Inc. Revenue in Crohn’s Disease Therapeutics Business (2015-2020))
11.1.5 Johnson and Johnson Services Inc. Recent Development
11.2 Pfizer Inc.
11.2.1 Pfizer Inc. Company Details
11.2.2 Pfizer Inc. Business Overview
11.2.3 Pfizer Inc. Crohn’s Disease Therapeutics Introduction
11.2.4 Pfizer Inc. Revenue in Crohn’s Disease Therapeutics Business (2015-2020)
11.2.5 Pfizer Inc. Recent Development
11.3 Allergan
11.3.1 Allergan Company Details
11.3.2 Allergan Business Overview
11.3.3 Allergan Crohn’s Disease Therapeutics Introduction
11.3.4 Allergan Revenue in Crohn’s Disease Therapeutics Business (2015-2020)
11.3.5 Allergan Recent Development
11.4 AbbVie Inc.
11.4.1 AbbVie Inc. Company Details
11.4.2 AbbVie Inc. Business Overview
11.4.3 AbbVie Inc. Crohn’s Disease Therapeutics Introduction
11.4.4 AbbVie Inc. Revenue in Crohn’s Disease Therapeutics Business (2015-2020)
11.4.5 AbbVie Inc. Recent Development
11.5 Takeda Pharmaceutical Company Limited
11.5.1 Takeda Pharmaceutical Company Limited Company Details
11.5.2 Takeda Pharmaceutical Company Limited Business Overview
11.5.3 Takeda Pharmaceutical Company Limited Crohn’s Disease Therapeutics Introduction
11.5.4 Takeda Pharmaceutical Company Limited Revenue in Crohn’s Disease Therapeutics Business (2015-2020)
11.5.5 Takeda Pharmaceutical Company Limited Recent Development
11.6 Celgene Corporation
11.6.1 Celgene Corporation Company Details
11.6.2 Celgene Corporation Business Overview
11.6.3 Celgene Corporation Crohn’s Disease Therapeutics Introduction
11.6.4 Celgene Corporation Revenue in Crohn’s Disease Therapeutics Business (2015-2020)
11.6.5 Celgene Corporation Recent Development
11.7 Perrigo Company PLC
11.7.1 Perrigo Company PLC Company Details
11.7.2 Perrigo Company PLC Business Overview
11.7.3 Perrigo Company PLC Crohn’s Disease Therapeutics Introduction
11.7.4 Perrigo Company PLC Revenue in Crohn’s Disease Therapeutics Business (2015-2020)
11.7.5 Perrigo Company PLC Recent Development
11.8 Ferring B.V.
11.8.1 Ferring B.V. Company Details
11.8.2 Ferring B.V. Business Overview
11.8.3 Ferring B.V. Crohn’s Disease Therapeutics Introduction
11.8.4 Ferring B.V. Revenue in Crohn’s Disease Therapeutics Business (2015-2020)
11.8.5 Ferring B.V. Recent Development
11.9 Salix Pharmaceuticals
11.9.1 Salix Pharmaceuticals Company Details
11.9.2 Salix Pharmaceuticals Business Overview
11.9.3 Salix Pharmaceuticals Crohn’s Disease Therapeutics Introduction
11.9.4 Salix Pharmaceuticals Revenue in Crohn’s Disease Therapeutics Business (2015-2020)
11.9.5 Salix Pharmaceuticals Recent Development
11.10 Gilead Sciences Inc.
11.10.1 Gilead Sciences Inc. Company Details
11.10.2 Gilead Sciences Inc. Business Overview
11.10.3 Gilead Sciences Inc. Crohn’s Disease Therapeutics Introduction
11.10.4 Gilead Sciences Inc. Revenue in Crohn’s Disease Therapeutics Business (2015-2020)
11.10.5 Gilead Sciences Inc. Recent Development
11.11 Genentech Inc.
10.11.1 Genentech Inc. Company Details
10.11.2 Genentech Inc. Business Overview
10.11.3 Genentech Inc. Crohn’s Disease Therapeutics Introduction
10.11.4 Genentech Inc. Revenue in Crohn’s Disease Therapeutics Business (2015-2020)
10.11.5 Genentech Inc. Recent Development
11.12 UCB India Private Limited.
10.12.1 UCB India Private Limited. Company Details
10.12.2 UCB India Private Limited. Business Overview
10.12.3 UCB India Private Limited. Crohn’s Disease Therapeutics Introduction
10.12.4 UCB India Private Limited. Revenue in Crohn’s Disease Therapeutics Business (2015-2020)
10.12.5 UCB India Private Limited. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
